Research Studies

Available Studies

St. Louis Pain Consultants is now accepting volunteers for the following Clinical Research Studies:

Abbott PROACTIVE

Enrollment Status: Open

Prospective, Randomized, double-Arm, open-label Study Assessing the Progression of SubjeCT’s ReceIVing a Neuromodulation System and the Impact on Subject OutcomEs with Remote Subject Monitoring

The PROACTIVE study is a post-market prospective, randomized, controlled study conducted to assess the impact of proactive monitoring and clinical outreach on patient outcomes in comparison to a traditional follow-up schedule. This study will provide data to assess the impact of data-driven monitoring on chronic pain patients. Subjects will be followed for 12 months on the study.

TENON Catamaran

Enrollment Status: Open

Prospective, Multi-Center, Single Arm Post-Market Feasibility Study of the Tenon Medical CATAMARAN™ SI Joint Fusion System.

The CATAMARAN SI Joint Fusion System is intended for sacroiliac joint fusion for conditions.

including sacroiliac joint disruptions and degenerative sacroiliitis. The objective of this post-market study is to evaluate the clinical outcomes of patients with sacroiliac joint disruptions or degenerative sacroiliitis treated with the CATAMARAN SI Joint Fusion System

SI Bone

Enrollment Status: Open

STACI iFuse TORQ for the treatment of Sacroiliac Joint Dysfunction

STACI is a prospective, multicenter, study of SIJ fusion using the SI Bone iFuse TORQ implant system. The goal of the study is to demonstrate the effectiveness of the device for its intended use.

SOLLIS SERENITY CM

Enrollment Status: Pending

A Phase 3, Prospective, Multicenter, Randomized, Double-blind, Sham-controlled Study of the Efficacy and Safety of STX-015 in the Treatment of Pain Associated with Lumbosacral Radiculopathy

The objective for this study is to compare the effect of STX-015 versus placebo in treating pain at the location associated with the worst lumbar and lumbosacral radiculopathy at Week 12 (3 months) after a single injection of STX-015 into the targeted lumbar or lumbosacral epidural space, compared to that from a blinded, control group of subjects who will undergo a sham injection designed to mimic the actual epidural injection of STX-015.

*Research participants may be compensated for time and travel

*Medical treatment and devices are provided to our patient at no cost